An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success (Q35101152)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success |
scientific article |
Statements
1 reference
An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success (English)
1 reference
Roger J Lewis
1 reference
Kert Viele
1 reference
Kristine Broglio
1 reference
Scott M Berry
1 reference
Alan E Jones
1 reference
1 July 2013
1 reference
1 reference
41
1 reference
7
1 reference
1674-1678
1 reference
Identifiers
1 reference
1 reference
1 reference